NEW YORK (GenomeWeb News) - Invitrogen will use Genetix's ClonePixFL technology in its process-development services, the company said today.
 
The technology will be offered through Invitrogen's PD-Direct offering.
 
Invitrogen also said it will develop applications to integrate ClonePixFL with its Revolution technology.
 
The Genetix ClonePixFL automatically images and selects mammalian cell colonies based upon a set of parameters.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.